摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ingenol-5,20-acetonide-3-tiglate | 1356490-35-1

中文名称
——
中文别名
——
英文名称
ingenol-5,20-acetonide-3-tiglate
英文别名
ingenol-5,20-acetonide-3-tiqlate;[(1S,4S,5S,6R,13S,14R,16R,18R)-5-hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.01,5.06,11.014,16]nonadeca-2,11-dien-4-yl] (E)-2-methylbut-2-enoate
ingenol-5,20-acetonide-3-tiglate化学式
CAS
1356490-35-1
化学式
C28H38O6
mdl
——
分子量
470.606
InChiKey
STFFIQHUWFISBB-NLUIYKAWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    582.2±50.0 °C(Predicted)
  • 密度:
    1.21±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    34
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    82.1
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ingenol-5,20-acetonide-3-tiglate盐酸 作用下, 以 为溶剂, 生成 ingenol-3-tigliate
    参考文献:
    名称:
    Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer
    摘要:
    Ingenol mebutate is the active ingredient in Picato (R) a new drug for the treatment of actinic keratosis. A number of derivatives related to ingenol mebutate were prepared by chemical synthesis from ingenol with the purpose of investigating the SAR and potency in assays relating to pro-inflammatory effects (induction of PMN oxidative burst and keratinocyte cytokine release), the potential of cell death induction, as well as the chemical stability. By modifications of the ingenol scaffold several prerequisites for activity were identified. The chemical stability of the compounds could be linked to an acyl migration mechanism. We were able to find analogues of ingenol mebutate with comparable in vitro properties. Some key features for potent and more stable ingenol derivatives have been identified. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2013.08.038
  • 作为产物:
    描述:
    ingenol4-二甲氨基吡啶对甲苯磺酸 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 生成 ingenol-5,20-acetonide-3-tiglate
    参考文献:
    名称:
    [EN] A METHOD OF PRODUCING INGENOL-3-ANGELATE
    [FR] PROCÉDÉ DE PRODUCTION D'INGÉNOL-3-ANGÉLATE
    摘要:
    本发明涉及从英吉利醇(II)制备英吉利醇-3-安吉酯(I)的方法。公式(I)和(II)。此外,本发明涉及用于从英吉利醇(II)合成英吉利醇-3-安吉酯(I)的中间体以及制备该中间体的方法。
    公开号:
    WO2012010172A1
点击查看最新优质反应信息

文献信息

  • [EN] INGENOL-3-ACYLATES I<br/>[FR] INGÉNOL-3-ACYLATES I
    申请人:LEO PHARMA AS
    公开号:WO2012085189A1
    公开(公告)日:2012-06-28
    The invention relates to compounds of general formula (I) wherein R is (C1-C7)alkyl, (C2-C7)alkenyl or (C2-C7)alkynyl; wherein R is substituted with R1; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.
    本发明涉及一般式(I)的化合物,其中R为(C1-C7)烷基,(C2-C7)烯基或(C2-C7)炔基;其中R被R1取代;以及其药学上可接受的盐、合物或溶剂化物,用于治疗、预防、治疗或改善对中性粒细胞氧化爆发刺激、角质细胞IL-8释放刺激或坏死诱导反应敏感的疾病或病情,可以单独使用或与一个或多个其他药物活性化合物结合使用。
  • METHOD OF PRODUCING INGENOL-3-ANGELATE
    申请人:Högberg Thomas
    公开号:US20130177952A1
    公开(公告)日:2013-07-11
    The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). Furthermore, the invention relates to intermediates useful for the synthesis of ingenol-3-angelate (I) from ingenol (II) and to methods of producing said intermediates.
    本发明涉及从英吉利醇(II)制备英吉利醇-3-丁二酸酯(I)的方法。此外,本发明还涉及用于从英吉利醇(II)合成英吉利醇-3-丁二酸酯(I)的中间体以及制备所述中间体的方法。
  • Semisynthesis of Ingenol 3-Angelate (PEP005): Efficient Stereoconservative Angeloylation of Alcohols
    作者:Xifu Liang、Gunnar Grue-Sørensen、Anders Petersen、Thomas Högberg
    DOI:10.1055/s-0032-1317415
    日期:——
    A high-yielding method was developed for the preparation of ingenol 3-angelate (PEP005, ingenol mebutate) via the corresponding 5,20-acetonide without concomitant isomerization of the angelate (Z-form) to the corresponding tiglate (E-form). The general scope of the stereoconservative esterification method was further evaluated on several different alcohols, giving the angelates in up to quantitative yield without isomerization to the tiglate.
  • US8901356B2
    申请人:——
    公开号:US8901356B2
    公开(公告)日:2014-12-02
  • US9388124B2
    申请人:——
    公开号:US9388124B2
    公开(公告)日:2016-07-12
查看更多